Linden Thomas Advisory Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Buy |
12,948
+561
| +5% | +$104K | 0.26% | 112 |
|
|
2025
Q1 | $2.6M | Buy |
12,387
+49
| +0.4% | +$10.3K | 0.34% | 81 |
|
|
2024
Q4 | $2.19M | Buy |
12,338
+35
| +0.3% | +$6.22K | 0.28% | 113 |
|
|
2024
Q3 | $2.43M | Sell |
12,303
-37
| -0.3% | -$7.31K | 0.33% | 79 |
|
|
2024
Q2 | $2.12M | Sell |
12,340
-217
| -2% | -$37.2K | 0.33% | 82 |
|
|
2024
Q1 | $2.29M | Buy |
12,557
+94
| +0.8% | +$17.1K | 0.37% | 62 |
|
|
2023
Q4 | $1.93M | Buy |
12,463
+121
| +1% | +$18.8K | 0.36% | 72 |
|
|
2023
Q3 | $1.84M | Sell |
12,342
-14
| -0.1% | -$2.09K | 0.41% | 56 |
|
|
2023
Q2 | $1.66M | Buy |
12,356
+345
| +3% | +$46.5K | 0.37% | 73 |
|
|
2023
Q1 | $1.91M | Buy |
12,011
+1,194
| +11% | +$190K | 0.47% | 47 |
|
|
2022
Q4 | $1.75M | Buy |
+10,817
| New | +$1.75M | 0.49% | 53 |
|